Irodalom:
1. Bembenek AE, Rosenberg R et al: Sentinel lymph node biopsy in colon cancer. A prospective multicenter
trial. Ann Surg (2007) 245:858-863.
2. Bilchik AJ, Compton C: Close collaboration between surgeon and pathologist is essential for accurate
staging of early colon cancer. Ann Surg (2007) 245:864-866.
3. Bori R, Vinh-Hung V et al: The impact of the largest metastasis size on nodal burden in colorectal
carcinomas: Implications for the sentinel lymph node theory in cancers of the large intestine. J Surg
Oncol (2007) 95:629-634.
4. Bujko K, Michalski W et al: Association between pathologic response in metastatic lymph nodes after
preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes
in a randomized trial. Int J Radiat Oncol Biol Phys (2007) 67:369-377.
5. den Dulk M, Marijnen CAM et al: Risk factors for adverse outcomes in patients with rectal cancer treated
with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg (2007) 246:83-90.
6. Edler D, Öhrling K et al: The number of lymph nodes – a prognostic factor in colorectal cancer. Acta
Oncol (2007) 46:975-981.
7. Hornick JL, Farraye FA et al: Clinicopathologic and immunohistochemical study of small apparently
“de novo” colorectal adenocarcinomas. Am J Surg Pathol (2007) 31:207.215.
8. Jass JR, O’Brien MJ et al: Reccomendations for the reporting of surgically resected specimens of colorectal
carcinoma. Virchows Arch (2007) 450:1-13.
9. Jass JR: Classification of colorectal cancer based on correlation of clinical, morphological and molecular
features . Histopathology (2007) 50:113-130.
294 Gastro Update 2008
10. Kazama Y, Watanabe T et al: Microsatellite instability in poorly differentiated adenocarcinomas of the
colon and rectum: relationship to clinicopathological features. J Clin Path (2007) 60:701-704.
11. Kim YM, Suh HJ et al: Additional lymph node examination from entire submission of residual mesenteric
tissue in colorectal cancer specimens may not add clinical and pathologic relevance. Hum Pathol (2007)
38:762-767.
12. Mäkinen MJ: Colorectal serrated adenocarcinoma. Histopathology (2007) 50:131-150.
13. Märkl B, Kerwel TG et al: Methylene blue injection into the rectal artery as a simple method to improve
lymph node harvest in rectal cancer. Mod Pathol (2007) 20:797-801.
14. Morris EJA, Maughan NJ et al: Identifying stage III colorectal cancer patients: The influence of the
patient, surgeon and pathologist. JCO (2007) 25:2573-2579.
15. Morris EJA, Maughan NJ et al: Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer?
The need for high quality pathology. Gut (2007) 56:1419-1425.
16. Nagtegaal I, Quirke P: Colorectal tumour deposits in the mesorectum and pericolon; a critical review.
Histopathology (2007) 51:141-149.
17. Prall F: Tumor budding in colorectal carcinoma. Histopathology (2007) 50:151-162.
18. Prall F, Weirich V et al: Phenotypes of invasion in sporadic colorectal carcinomas related to aberrations
of the adenomatous polyposis coli (APC) gene. Histopathology (2007) 50:318-330.
19. Quirke P, Morris E: Reporting colorectal cancer. Histopathology (2007) 50:103-112.
20. Stojadinovic A, Nissan A et al: Prospective randomized study comparing sentinel lymph node evaluation
with standard pathologic evaluation for the staging of colon carcinoma. Ann Surg (2007) 245:846-857.
The Royal College of Pathologists Standards and Datasets for Reporting Cancers – Dataset for colorectal
cancer (2nd edition) September 2007. http://www.rcpath.org/resources/pdf/G049 – Colorectal DatasetSep07.pdf
21. Ueno M, Mochizuki H et al: Extramural cancer deposits without nodal structure in colorectal cancer:
optimal categorization for prognostic staging. Am J Clin Path (2007) 127:287-294.
22. Xu F, Wang F et al: Classification based on the combination of molecular and pathologic predictors is
superior to molecular classifications on prognosis in colorectal carcinoma. Clin Cancer Res (2007)
13:5082-5088.
